--- license: cc-by-4.0 pretty_name: FKBP12 F36V Binder Designs (PDB 1BL4) task_categories: - tabular-regression - graph-ml - other size_categories: - n<1K configs: - config_name: default data_files: - split: train path: designs.csv language: - en tags: - chemistry - biology - drug-discovery - FKBP12 - FKBP1A - FKBP - F36V - FKBP12-F36V - P62942 - immunophilin - PPIase - peptidyl-prolyl-isomerase - bump-hole - bumped-ligand - chemical-biology - chemically-induced-proximity - induced-proximity - dTAG - degron - degradation-tag - AP1497 - SLF - synthetic-ligand-of-FKBP - rapamycin - FK506 - tacrolimus - chemical-inducer-of-dimerization - CID - molecular-glue - bifunctional - heterobifunctional - PROTAC - RIPTAC - targeted-protein-degradation - protein-protein-interaction - ternary-complex - 1BL4 - molecular-docking - autodock-vina - protein-ligand-complex - structure-based-drug-design - de-novo-design - generative-design - generative-ai - ai-generated - genetic-algorithm - GA-II - synthetic-data - small-molecule - SMILES - SDF - cheminformatics - computational-chemistry - virtual-screening - TC-43 - technetium --- # FKBP12 F36V Binder Designs (PDB 1BL4) **165** de novo, generative-AI–designed small molecules docked into the engineered **FKBP12 F36V** cavity of **[1BL4](https://www.rcsb.org/structure/1BL4)** (1.9 Å), each supplied as a complete protein–ligand complex. Molecules were generated by the Technetium **`TC-43.ai`** engine (GA-II generation). Target setup, receptor validation and dataset curation by **Claude Code**. ## Target FKBP12 ([P62942](https://www.uniprot.org/uniprotkb/P62942)) is a 12 kDa peptidyl-prolyl isomerase and the receptor for FK506 and rapamycin. The **F36V** mutation enlarges the ligand cavity, creating a "hole" that accepts correspondingly "bumped" synthetic ligands while wild-type FKBP12 does not — the basis of the bump-hole systems used throughout chemically induced proximity, including dTAG degron tagging and heterobifunctional proximity-inducing molecules. PDB 1BL4 is *FKBP mutant F36V complexed with a remodeled synthetic ligand* — the reference bumped ligand **AP1497** (693.8 Da). The receptor here is the deposited dimer: **chains A and B, 107 residues each** (mature FKBP12, initiator Met removed, so the mutation sits literally at position 36 and receptor numbering is UniProt − 1). AP1497 is retained in the chain B cavity; the designs occupy the **chain A** cavity. ## Binding site All 165 designs bind the chain A FKBP cavity. Contact frequencies across the set: | residue | % of poses | | residue | % of poses | |---|---|---|---|---| | Trp59 | 100% | | Asp37 | 77% | | Tyr82 | 100% | | **Val36** | **70%** | | Ile56 | 100% | | Glu54 | 60% | | Val55 | 100% | | Phe99 | 47% | | Tyr26 | 98% | | Ile91 | 27% | | Ile90 | 95% | | Gln53 | 15% | | Phe46 | 87% | | Gly28 | 15% | Trp59, Tyr82, Ile56 and Val55 form the invariant floor of the cavity — every pose touches all four. ### Val36 engagement — read this before selecting compounds **Val36 is the mutation.** It is the only residue that distinguishes this receptor from wild-type FKBP12, so a design that does not contact it has no structural basis for preferring F36V over wild type. Wild-type FKBP12 is one of the most abundant cytosolic proteins in mammalian cells, which makes that distinction the difference between a usable chemical-biology tool and one swamped by the endogenous pool. - **`val36_contact = True` — 115 of 165 designs (70%).** Use this subset where F36V discrimination matters. - The remaining 50 bind the conserved cavity floor only and should be treated as generic FKBP12 binders. This dataset does not include wild-type FKBP12 counter-docking; Val36 contact is a structural proxy, not a measured selectivity. ## Contents | file | description | |---|---| | `designs.csv` | one row per design — 29 columns | | `ligands.sdf` | all 165 poses, bond orders and formal charges assigned from the SMILES template | | `receptor_1BL4_FKBP12_F36V.pdb` | chains A + B plus the AP1497 reference ligand | | `structures/` | 165 complete protein–ligand complexes | ### Columns `design_id`, `rank`, `smiles`, `pose_smiles`, `stereo_check`, `vina_score`, `ligand_efficiency`, `mw`, `clogp`, `tpsa`, `qed`, `hbd`, `hba`, `rotatable_bonds`, `heavy_atoms`, `rings`, `aromatic_rings`, `fsp3`, `formal_charge`, `murcko_scaffold`, `chemotype_cluster`, `n_contact_residues`, `contact_residues`, `val36_contact`, `min_dist_protein_ang`, `min_dist_ap1497_ang`, `steric_clash`, `ecfp4_similarity_to_ap1497`, `pose_file` ## Set characteristics | | designs (mean) | AP1497 reference | |---|---|---| | Vina score | −10.56 (best −12.30) | — | | ligand efficiency | 0.34 | — | | molecular weight | 433 | 694 | | heavy atoms | 31 | 50 | | cLogP | 3.17 | 5.99 | | TPSA | 87.6 | 139.3 | | rotatable bonds | 6.3 | 17 | | QED | 0.44 | 0.17 | All 165 SMILES are unique, spanning 142 Murcko scaffolds and **66 chemotypes** (Butina on ECFP4 at Tanimoto 0.4), with 46 singletons and a largest cluster of 33. **The designs are chemically independent of the reference.** Maximum ECFP4 similarity to AP1497 across the set is **0.19** (mean 0.13), and **none of the 165 contains a pipecolate ester** — the canonical FKBP-binding motif shared by FK506, rapamycin, SLF and AP1497. The set explores the cavity with different chemistry rather than re-deriving the known pharmacophore. Whether that is an advantage or a liability depends on how much the pipecolate anchor contributes to the binding you need. ## Pose quality Docking was rigid-receptor with a fixed receptor across the whole set (verified: a single set of receptor and AP1497 coordinates in all 165 files). Poses are sterically clean: - closest heavy-atom contact to protein: median **2.97 Å** (5th–95th percentile 2.67–3.11) - only **3 of 165** poses have any atom within 2.5 Å of the protein (`steric_clash`) - **zero** poses clash with AP1497 in the adjacent chain B cavity - all 165 ligands round-tripped 3D pose → bond orders → SMILES with matching connectivity Scores were pre-filtered upstream at −10.0 kcal/mol, so the set contains nothing above that value and the distribution describes the surviving tail only. Treat scores as a ranking signal, not affinity. ## Citation Molecules generated by the Technetium `TC-43.ai` engine. Receptor validation and dataset curation by Claude Code. Released under CC-BY-4.0.